Niquitin Mini Citrus (Nicotine)

Nicotine in this product binds to nicotinic acetylcholine receptors in the brain, providing a controlled level of stimulation that compensates for the deficit created when a person stops smoking. This receptor activation reduces the intensity of withdrawal and cravings, making it easier to maintain abstinence.

The specific dose and dosing schedule are determined by the prescribing healthcare professional based on the individual’s smoking history, dependence level, and treatment goals. Patients should follow the prescriber’s instructions and not alter the amount without medical advice.

Safety data for nicotine replacement products in pregnancy and lactation are limited. The product’s pregnancy category is not established, so clinicians should weigh potential risks and benefits and discuss options with the patient. Generally, nicotine exposure is discouraged during pregnancy and breastfeeding unless deemed essential.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with nicotine patches or gum, Niquitin Mini Citrus delivers nicotine via the oral mucosa, offering rapid absorption and flexible dosing. It may provide quicker relief of cravings than a patch, while avoiding the chewing required for gum. Choice of product depends on patient preference, tolerability, and clinical considerations.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep it out of reach of children and do not use if the packaging is damaged or the product appears discoloured.

The product is placed in the mouth and allowed to dissolve slowly against the oral mucosa, as directed by the prescriber. Patients should avoid swallowing the entire dose at once and should follow the specific instructions regarding frequency and duration of use.

Serious risks include severe allergic reactions such as rash, swelling, or anaphylaxis; cardiovascular events like chest pain, palpitations, or hypertension; and persistent vomiting or respiratory difficulty that may require immediate medical attention. Patients should seek urgent care if any of these symptoms occur.

Individuals with known hypersensitivity to nicotine or any excipients in the formulation should avoid the product. It is also contraindicated in patients with uncontrolled hypertension, recent myocardial infarction, serious cardiac arrhythmias, or those who are pregnant or breastfeeding without medical guidance.